United States Biotechnology & Medical Research

Editas Medicine Inc (EDIT)

Track

Track

Editas Medicine executives recently offloaded shares, totaling approximately $34,000 in net value over the past quarter. Key leadership, including the CEO and CFO, executed these sales following the August earnings report. Despite an 8.2% stock decline recently, these transactions reflect ongoing divestment patterns among internal stakeholders rather than new acquisition activity.
Ticker: EDIT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Editas Medicine Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
4.1
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
199.83
Quantity 55,248 +40.2%
Value US$3,674,967
4.3
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
59.10
Quantity 91,902 -3.0%
Value US$1,341,725
2.2
Parison Amy SVP, Chief Financial Officer Officer
Transaction date
Sale
Price
344.29
Quantity 95,807 +42.1%
Value US$1,304,544
4.3
O'Neill Gilmore Neil Officer; Director Executive Director
Transaction date
Proposed sale
Price
3.28
Quantity 5,100
Value US$16,728
4.1
Burkly Linda Officer Officer
Transaction date
Proposed sale
Price
3.28
Quantity 700
Value US$2,296
2.2
Parison Amy SVP, Chief Financial Officer Officer
Transaction date
Sale
Price
2.58
Quantity 678 -4.5%
Value US$1,749
4.1
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
2.67
Quantity 4,928 -7.3%
Value US$13,158
4.1
Burkly Linda Officer Officer
Transaction date
Proposed sale
Price
2.88
Quantity 5,500
Value US$15,840
4.3
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
2.70
Quantity 15,380 -5.8%
Value US$41,543
4.3
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
2.70
Quantity 15,380 -5.8%
Value US$41,543
4.1
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
2.70
Quantity 731 -1.1%
Value US$1,975
2.2
Parison Amy SVP, Chief Financial Officer Officer
Transaction date
Sale
Price
2.70
Quantity 464 -3.0%
Value US$1,253
4.3
O'Neill Gilmore Neil Officer; Director Executive Director
Transaction date
Proposed sale
Price
3.08
Quantity 15,000
Value US$46,200
4.3
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
2.02
Quantity 5,394 -2.0%
Value US$10,894
2.2
Parison Amy SVP, Chief Financial Officer Officer
Transaction date
Sale
Price
2.02
Quantity 474 -3.0%
Value US$957
4.1
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
2.02
Quantity 749 -1.1%
Value US$1,513
4.3
O'Neill Gilmore Neil Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.89
Quantity 6,000
Value US$11,340
4.1
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
2.15
Quantity 713 -1.0%
Value US$1,535
4.3
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
2.15
Quantity 5,603 -2.0%
Value US$12,064
2.2
Parison Amy SVP, Chief Financial Officer Officer
Transaction date
Sale
Price
2.15
Quantity 461 -2.8%
Value US$993
4.3
O'Neill Gilmore Neil Officer; Director Executive Director
Transaction date
Proposed sale
Price
2.50
Quantity 7,000
Value US$17,500
4.1
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Planned sale
Price
2.60
Quantity 710 -1.0%
Value US$1,843
4.3
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
2.60
Quantity 5,592 -2.0%
Value US$14,517
2.2
Parison Amy SVP, Chief Financial Officer Officer
Transaction date
Sale
Price
2.60
Quantity 458 -2.7%
Value US$1,189
4.3
O'Neill Gilmore Neil Officer; Director Executive Director
Transaction date
Proposed sale
Price
2.73
Quantity 7,000
Value US$19,110
4.1
Burkly Linda Officer Officer
Transaction date
Proposed sale
Price
2.73
Quantity 800
Value US$2,184
2.2
Parison Amy SVP, Chief Financial Officer Officer
Transaction date
Sale
Price
2.58
Quantity 679 -3.9%
Value US$1,752
4.1
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
2.49
Quantity 5,121 -7.4%
Value US$12,757
4.1
Burkly Linda Officer Officer
Transaction date
Proposed sale
Price
3.46
Quantity 7,500
Value US$25,950
4.3
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
1.72
Quantity 15,192 -5.1%
Value US$26,196
4.1
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
1.72
Quantity 726 -1.0%
Value US$1,252
2.2
Parison Amy SVP, Chief Financial Officer Officer
Transaction date
Sale
Price
1.72
Quantity 446 -2.5%
Value US$769
4.3
O'Neill Gilmore Neil Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.87
Quantity 20,000
Value US$37,400
4.1
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
1.71
Quantity 2,891 -4.0%
Value US$4,946
4.3
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
1.71
Quantity 16,632 -5.3%
Value US$28,452
3.7
Lucera Erick EVP, CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
1.71
Quantity 4,109 -3.5%
Value US$7,030
4.3
O'Neill Gilmore Neil Officer; Director Executive Director
Transaction date
Proposed sale
Price
1.86
Quantity 35,000
Value US$65,100
3.7
Lucera Erick Officer Officer
Transaction date
Proposed sale
Price
1.86
Quantity 8,000
Value US$14,880
4.1
Burkly Linda Officer Officer
Transaction date
Proposed sale
Price
1.86
Quantity 6,000
Value US$11,160
4.3
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
2.08
Quantity 1,618 -0.5%
Value US$3,361
4.4
Mei Baisong EVP, CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
2.08
Quantity 541 -0.4%
Value US$1,124
4.4
Mei Baisong EVP, CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
3.42
Quantity 518 -0.4%
Value US$1,774
4.3
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
3.42
Quantity 1,555 -0.5%
Value US$5,325
4.3
O'Neill Gilmore Neil Officer; Director Executive Director
Transaction date
Proposed sale
Price
3.92
Quantity 3,000
Value US$11,760
4.4
Mei Baisong Officer Officer
Transaction date
Proposed sale
Price
3.92
Quantity 1,000
Value US$3,920
4.1
Burkly Linda EVP, CHIEF SCIENTIFIC OFFICER Officer
Transaction date
Sale
Price
5.42
Quantity 11,886 -14.0%
Value US$64,370
4.1
Burkly Linda Officer Officer
Transaction date
Proposed sale
Price
5.61
Quantity 26,000
Value US$145,860
4.4
Mei Baisong EVP, CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
5.21
Quantity 6,619 -4.7%
Value US$34,456
4.4
Mei Baisong Officer Officer
Transaction date
Proposed sale
Price
5.61
Quantity 14,000
Value US$78,540
4.4
Mei Baisong EVP, CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
5.50
Quantity 511 -0.4%
Value US$2,808
4.3
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
5.50
Quantity 12,191 -3.7%
Value US$66,997
4.3
O'Neill Gilmore Neil Officer; Director Executive Director
Transaction date
Proposed sale
Price
5.32
Quantity 24,000
Value US$127,680
4.4
Mei Baisong Officer Officer
Transaction date
Proposed sale
Price
5.32
Quantity 1,000
Value US$5,320
3.7
Lucera Erick EVP, CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
5.61
Quantity 22,337 -16.1%
Value US$125,404
3.7
Lucera Erick Officer Officer
Transaction date
Proposed sale
Price
5.71
Quantity 45,000
Value US$256,950
3.2
Hopfield Jessica Non-Executive Director
Transaction date
Purchase
Price
5.64
Quantity 45,000 +198.2%
Value US$253,868
3.2
Hopfield Jessica Non-Executive Director
Transaction date
Purchase
Price
5.64
Quantity 45,000 +198.2%
Value US$253,868
4.3
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
9.42
Quantity 77,824 -19.2%
Value US$732,884
4.4
Mei Baisong SVP, CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
9.42
Quantity 20,327 -12.6%
Value US$191,425
4.3
O'Neill Gilmore Neil Officer; Director Executive Director
Transaction date
Proposed sale
Price
8.86
Quantity 140,000
Value US$1,240,400
3.8
Eaton Bruce EVP, CBO AND CTO Officer
Transaction date
Sale
Price
10.90
Quantity 103 -0.1%
Value US$1,122
3.8
Eaton Bruce EVP, CBO AND CTO Officer
Transaction date
Sale
Price
8.21
Quantity 695 -0.9%
Value US$5,706
3.8
Eaton Bruce EVP, CBO AND CTO Officer
Transaction date
Sale
Price
8.40
Quantity 139 -0.2%
Value US$1,168
3.8
Eaton Bruce EVP, CBO AND CTO Officer
Transaction date
Sale
Price
8.82
Quantity 103 -0.1%
Value US$908
3.8
Eaton Bruce EVP, CBO AND CTO Officer
Transaction date
Sale
Price
8.59
Quantity 702 -0.9%
Value US$6,033
3.8
Eaton Bruce EVP, CBO AND CTO Officer
Transaction date
Sale
Price
8.39
Quantity 141 -0.2%
Value US$1,183
4.4
Mei Baisong SVP, CHIEF MEDICAL OFFICER Officer
Transaction date
Sale
Price
8.80
Quantity 4,317 -5.7%
Value US$37,990
3.8
Eaton Bruce EVP, CBO AND CTO Officer
Transaction date
Sale
Price
9.50
Quantity 105 -0.1%
Value US$998
4.3
O'Neill Gilmore Neil CEO Executive Director
Transaction date
Sale
Price
9.50
Quantity 6,486 -4.7%
Value US$61,638
4.3
Gilmore Neil O'Neill Officer; Director Executive Director
Transaction date
Proposed sale
Price
9.18
Quantity 8,500
Value US$78,030
4.1
ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
9.87
Quantity 949 -0.9%
Value US$9,369
3.8
Eaton Bruce EVP, CBO AND CTO Officer
Transaction date
Sale
Price
9.87
Quantity 668 -0.9%
Value US$6,594
4.1
Michelle Robertson Officer Officer
Transaction date
Proposed sale
Price
3.62
Quantity 3,000
Value US$10,845
3.8
Eaton Bruce EVP, CBO AND CTO Officer
Transaction date
Sale
Price
9.51
Quantity 135 -0.2%
Value US$1,284
4.1
ROBERTSON MICHELLE EVP, CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
8.89
Quantity 184 -0.2%
Value US$1,636
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-04 2026-09-03 S Sale
4.1
Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER

Officer
55,248 +40.2%
199.83
US$3,674,967 		55,248 +40.2% 199.83 US$3,674,967
2026-09-04 2026-09-03 S Sale
4.3
O'Neill Gilmore Neil

CEO

Executive Director
91,902 -3.0%
59.10
US$1,341,725 		91,902 -3.0% 59.10 US$1,341,725
2026-09-04 2026-09-03 S Sale
2.2
Parison Amy

SVP, Chief Financial Officer

Officer
95,807 +42.1%
344.29
US$1,304,544 		95,807 +42.1% 344.29 US$1,304,544
2026-08-31 2026-09-03 PrS Proposed sale
4.3
O'Neill Gilmore Neil

Officer; Director

Executive Director
5,100
3.28
US$16,728 		5,100 3.28 US$16,728
2026-08-31 2026-09-03 PrS Proposed sale
4.1
Burkly Linda

Officer

Officer
700
3.28
US$2,296 		700 3.28 US$2,296
2026-08-05 2026-08-03 S Sale
2.2
Parison Amy

SVP, Chief Financial Officer

Officer
678 -4.5%
2.58
US$1,749 		678 -4.5% 2.58 US$1,749
2026-07-29 2026-07-28 S Sale
4.1
Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER

Officer
4,928 -7.3%
2.67
US$13,158 		4,928 -7.3% 2.67 US$13,158
2026-07-21 2026-07-27 PrS Proposed sale
4.1
Burkly Linda

Officer

Officer
5,500
2.88
US$15,840 		5,500 2.88 US$15,840
2026-06-05 2026-06-03 S Sale
4.3
O'Neill Gilmore Neil

CEO

Executive Director
15,380 -5.8%
2.70
US$41,543 		15,380 -5.8% 2.70 US$41,543
2026-06-05 2026-06-03 S Sale
4.3
O'Neill Gilmore Neil

CEO

Executive Director
15,380 -5.8%
2.70
US$41,543 		15,380 -5.8% 2.70 US$41,543
2026-06-05 2026-06-03 S Sale
4.1
Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER

Officer
731 -1.1%
2.70
US$1,975 		731 -1.1% 2.70 US$1,975
2026-06-05 2026-06-03 S Sale
2.2
Parison Amy

SVP, Chief Financial Officer

Officer
464 -3.0%
2.70
US$1,253 		464 -3.0% 2.70 US$1,253
2026-05-29 2026-06-03 PrS Proposed sale
4.3
O'Neill Gilmore Neil

Officer; Director

Executive Director
15,000
3.08
US$46,200 		15,000 3.08 US$46,200
2026-03-04 2026-03-03 S Sale
4.3
O'Neill Gilmore Neil

CEO

Executive Director
5,394 -2.0%
2.02
US$10,894 		5,394 -2.0% 2.02 US$10,894
2026-03-04 2026-03-03 S Sale
2.2
Parison Amy

SVP, Chief Financial Officer

Officer
474 -3.0%
2.02
US$957 		474 -3.0% 2.02 US$957
2026-03-04 2026-03-03 S Sale
4.1
Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER

Officer
749 -1.1%
2.02
US$1,513 		749 -1.1% 2.02 US$1,513
2026-02-27 2026-03-03 PrS Proposed sale
4.3
O'Neill Gilmore Neil

Officer; Director

Executive Director
6,000
1.89
US$11,340 		6,000 1.89 US$11,340
2025-12-04 2025-12-03 S Sale
4.1
Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER

Officer
713 -1.0%
2.15
US$1,535 		713 -1.0% 2.15 US$1,535
2025-12-04 2025-12-03 S Sale
4.3
O'Neill Gilmore Neil

CEO

Executive Director
5,603 -2.0%
2.15
US$12,064 		5,603 -2.0% 2.15 US$12,064
2025-12-04 2025-12-03 S Sale
2.2
Parison Amy

SVP, Chief Financial Officer

Officer
461 -2.8%
2.15
US$993 		461 -2.8% 2.15 US$993
2025-12-01 2025-12-03 PrS Proposed sale
4.3
O'Neill Gilmore Neil

Officer; Director

Executive Director
7,000
2.50
US$17,500 		7,000 2.50 US$17,500
2025-09-04 2025-09-03 PlS Planned sale
4.1
Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER

Officer
710 -1.0%
2.60
US$1,843 		710 -1.0% 2.60 US$1,843
2025-09-04 2025-09-03 S Sale
4.3
O'Neill Gilmore Neil

CEO

Executive Director
5,592 -2.0%
2.60
US$14,517 		5,592 -2.0% 2.60 US$14,517
2025-09-04 2025-09-03 S Sale
2.2
Parison Amy

SVP, Chief Financial Officer

Officer
458 -2.7%
2.60
US$1,189 		458 -2.7% 2.60 US$1,189
2025-08-29 2025-09-03 PrS Proposed sale
4.3
O'Neill Gilmore Neil

Officer; Director

Executive Director
7,000
2.73
US$19,110 		7,000 2.73 US$19,110
2025-08-29 2025-09-03 PrS Proposed sale
4.1
Burkly Linda

Officer

Officer
800
2.73
US$2,184 		800 2.73 US$2,184
2025-08-08 2025-08-07 S Sale
2.2
Parison Amy

SVP, Chief Financial Officer

Officer
679 -3.9%
2.58
US$1,752 		679 -3.9% 2.58 US$1,752
2025-08-04 2025-07-31 S Sale
4.1
Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER

Officer
5,121 -7.4%
2.49
US$12,757 		5,121 -7.4% 2.49 US$12,757
2025-07-30 2025-07-31 PrS Proposed sale
4.1
Burkly Linda

Officer

Officer
7,500
3.46
US$25,950 		7,500 3.46 US$25,950
2025-06-04 2025-06-03 S Sale
4.3
O'Neill Gilmore Neil

CEO

Executive Director
15,192 -5.1%
1.72
US$26,196 		15,192 -5.1% 1.72 US$26,196
2025-06-04 2025-06-03 S Sale
4.1
Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER

Officer
726 -1.0%
1.72
US$1,252 		726 -1.0% 1.72 US$1,252
2025-06-04 2025-06-03 S Sale
2.2
Parison Amy

SVP, Chief Financial Officer

Officer
446 -2.5%
1.72
US$769 		446 -2.5% 1.72 US$769
2025-06-02 2025-06-03 PrS Proposed sale
4.3
O'Neill Gilmore Neil

Officer; Director

Executive Director
20,000
1.87
US$37,400 		20,000 1.87 US$37,400
2025-03-05 2025-03-04 S Sale
4.1
Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER

Officer
2,891 -4.0%
1.71
US$4,946 		2,891 -4.0% 1.71 US$4,946
2025-03-05 2025-03-04 S Sale
4.3
O'Neill Gilmore Neil

CEO

Executive Director
16,632 -5.3%
1.71
US$28,452 		16,632 -5.3% 1.71 US$28,452
2025-03-05 2025-03-04 S Sale
3.7
Lucera Erick

EVP, CHIEF FINANCIAL OFFICER

Officer
4,109 -3.5%
1.71
US$7,030 		4,109 -3.5% 1.71 US$7,030
2025-02-28 2025-03-03 PrS Proposed sale
4.3
O'Neill Gilmore Neil

Officer; Director

Executive Director
35,000
1.86
US$65,100 		35,000 1.86 US$65,100
2025-02-28 2025-03-03 PrS Proposed sale
3.7
Lucera Erick

Officer

Officer
8,000
1.86
US$14,880 		8,000 1.86 US$14,880
2025-02-28 2025-03-03 PrS Proposed sale
4.1
Burkly Linda

Officer

Officer
6,000
1.86
US$11,160 		6,000 1.86 US$11,160
2024-12-05 2024-12-03 S Sale
4.3
O'Neill Gilmore Neil

CEO

Executive Director
1,618 -0.5%
2.08
US$3,361 		1,618 -0.5% 2.08 US$3,361
2024-12-05 2024-12-03 S Sale
4.4
Mei Baisong

EVP, CHIEF MEDICAL OFFICER

Officer
541 -0.4%
2.08
US$1,124 		541 -0.4% 2.08 US$1,124
2024-09-06 2024-09-04 S Sale
4.4
Mei Baisong

EVP, CHIEF MEDICAL OFFICER

Officer
518 -0.4%
3.42
US$1,774 		518 -0.4% 3.42 US$1,774
2024-09-06 2024-09-04 S Sale
4.3
O'Neill Gilmore Neil

CEO

Executive Director
1,555 -0.5%
3.42
US$5,325 		1,555 -0.5% 3.42 US$5,325
2024-08-29 2024-09-03 PrS Proposed sale
4.3
O'Neill Gilmore Neil

Officer; Director

Executive Director
3,000
3.92
US$11,760 		3,000 3.92 US$11,760
2024-08-29 2024-09-03 PrS Proposed sale
4.4
Mei Baisong

Officer

Officer
1,000
3.92
US$3,920 		1,000 3.92 US$3,920
2024-07-26 2024-07-25 S Sale
4.1
Burkly Linda

EVP, CHIEF SCIENTIFIC OFFICER

Officer
11,886 -14.0%
5.42
US$64,370 		11,886 -14.0% 5.42 US$64,370
2024-07-18 2024-07-25 PrS Proposed sale
4.1
Burkly Linda

Officer

Officer
26,000
5.61
US$145,860 		26,000 5.61 US$145,860
2024-07-22 2024-07-19 S Sale
4.4
Mei Baisong

EVP, CHIEF MEDICAL OFFICER

Officer
6,619 -4.7%
5.21
US$34,456 		6,619 -4.7% 5.21 US$34,456
2024-07-18 2024-07-19 PrS Proposed sale
4.4
Mei Baisong

Officer

Officer
14,000
5.61
US$78,540 		14,000 5.61 US$78,540
2024-06-06 2024-06-04 S Sale
4.4
Mei Baisong

EVP, CHIEF MEDICAL OFFICER

Officer
511 -0.4%
5.50
US$2,808 		511 -0.4% 5.50 US$2,808
2024-06-06 2024-06-04 S Sale
4.3
O'Neill Gilmore Neil

CEO

Executive Director
12,191 -3.7%
5.50
US$66,997 		12,191 -3.7% 5.50 US$66,997
2024-05-31 2024-06-03 PrS Proposed sale
4.3
O'Neill Gilmore Neil

Officer; Director

Executive Director
24,000
5.32
US$127,680 		24,000 5.32 US$127,680
2024-05-31 2024-06-03 PrS Proposed sale
4.4
Mei Baisong

Officer

Officer
1,000
5.32
US$5,320 		1,000 5.32 US$5,320
2024-05-22 2024-05-20 S Sale
3.7
Lucera Erick

EVP, CHIEF FINANCIAL OFFICER

Officer
22,337 -16.1%
5.61
US$125,404 		22,337 -16.1% 5.61 US$125,404
2024-05-17 2024-05-17 PrS Proposed sale
3.7
Lucera Erick

Officer

Officer
45,000
5.71
US$256,950 		45,000 5.71 US$256,950
2024-05-14 2024-05-13 B Purchase
3.2
Hopfield Jessica
Non-Executive Director
45,000 +198.2%
5.64
US$253,868 		45,000 +198.2% 5.64 US$253,868
2024-05-14 2024-05-13 B Purchase
3.2
Hopfield Jessica
Non-Executive Director
45,000 +198.2%
5.64
US$253,868 		45,000 +198.2% 5.64 US$253,868
2024-03-05 2024-03-05 S Sale
4.3
O'Neill Gilmore Neil

CEO

Executive Director
77,824 -19.2%
9.42
US$732,884 		77,824 -19.2% 9.42 US$732,884
2024-03-05 2024-03-04 S Sale
4.4
Mei Baisong

SVP, CHIEF MEDICAL OFFICER

Officer
20,327 -12.6%
9.42
US$191,425 		20,327 -12.6% 9.42 US$191,425
2024-03-04 2024-03-04 PrS Proposed sale
4.3
O'Neill Gilmore Neil

Officer; Director

Executive Director
140,000
8.86
US$1,240,400 		140,000 8.86 US$1,240,400
2023-12-07 2023-12-05 S Sale
3.8
Eaton Bruce

EVP, CBO AND CTO

Officer
103 -0.1%
10.90
US$1,122 		103 -0.1% 10.90 US$1,122
2023-11-16 2023-11-14 S Sale
3.8
Eaton Bruce

EVP, CBO AND CTO

Officer
695 -0.9%
8.21
US$5,706 		695 -0.9% 8.21 US$5,706
2023-11-09 2023-11-07 S Sale
3.8
Eaton Bruce

EVP, CBO AND CTO

Officer
139 -0.2%
8.40
US$1,168 		139 -0.2% 8.40 US$1,168
2023-09-07 2023-09-06 S Sale
3.8
Eaton Bruce

EVP, CBO AND CTO

Officer
103 -0.1%
8.82
US$908 		103 -0.1% 8.82 US$908
2023-08-15 2023-08-11 S Sale
3.8
Eaton Bruce

EVP, CBO AND CTO

Officer
702 -0.9%
8.59
US$6,033 		702 -0.9% 8.59 US$6,033
2023-08-10 2023-08-08 S Sale
3.8
Eaton Bruce

EVP, CBO AND CTO

Officer
141 -0.2%
8.39
US$1,183 		141 -0.2% 8.39 US$1,183
2023-07-21 2023-07-19 S Sale
4.4
Mei Baisong

SVP, CHIEF MEDICAL OFFICER

Officer
4,317 -5.7%
8.80
US$37,990 		4,317 -5.7% 8.80 US$37,990
2023-06-07 2023-06-05 S Sale
3.8
Eaton Bruce

EVP, CBO AND CTO

Officer
105 -0.1%
9.50
US$998 		105 -0.1% 9.50 US$998
2023-06-07 2023-06-05 S Sale
4.3
O'Neill Gilmore Neil

CEO

Executive Director
6,486 -4.7%
9.50
US$61,638 		6,486 -4.7% 9.50 US$61,638
2023-06-02 2023-06-05 PrS Proposed sale
4.3
Gilmore Neil O'Neill

Officer; Director

Executive Director
8,500
9.18
US$78,030 		8,500 9.18 US$78,030
2023-05-15 2023-05-11 S Sale
4.1
ROBERTSON MICHELLE

EVP, CHIEF FINANCIAL OFFICER

Officer
949 -0.9%
9.87
US$9,369 		949 -0.9% 9.87 US$9,369
2023-05-15 2023-05-11 S Sale
3.8
Eaton Bruce

EVP, CBO AND CTO

Officer
668 -0.9%
9.87
US$6,594 		668 -0.9% 9.87 US$6,594
2023-05-11 2023-05-11 PrS Proposed sale
4.1
Michelle Robertson

Officer

Officer
3,000
3.62
US$10,845 		3,000 3.62 US$10,845
2023-05-11 2023-05-09 S Sale
3.8
Eaton Bruce

EVP, CBO AND CTO

Officer
135 -0.2%
9.51
US$1,284 		135 -0.2% 9.51 US$1,284
2023-03-06 2023-03-03 S Sale
4.1
ROBERTSON MICHELLE

EVP, CHIEF FINANCIAL OFFICER

Officer
184 -0.2%
8.89
US$1,636 		184 -0.2% 8.89 US$1,636
Explore more

More insider trading research around Editas Medicine Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America